Indefinite Delivery Contract HHSN272201700048I

The National Institute of Allergy and Infectious Diseases awarded a single award indefinite delivery contract to Mriglobal, doing business as Midwest Research Institute, with a potential value of $545,452,906 and period of performance from September 1, 2021 through August 31, 2028. The contract provides comprehensive and rapid response services to support NIAID's research programs including clinical trials, manufacturing, nonclinical studies, analytics, and basic research. A $2,000 firm fixed...

The National Institutes of Health's National Institute of Child Health and Human Development awarded an indefinite delivery contract to The Regents of the University of California, San Francisco to conduct clinical trials in support of contraceptive development. With a potential value of $5 million and a period of performance through July 2027, this multiple-award contract enables the agency to issue task orders for phase I-IV contraceptive trials in women and treatment trials for gynecologic...

The National Cancer Institute awarded an indefinite delivery/indefinite quantity multiple award contract to provide operational, administrative, regulatory, information technology, and logistical support services to support participation in multi-institutional cancer trials. Valued at up to $548 million over 10 years, the contract includes six task areas: project kick-off and transition activities, CTSU core support services and systems, awareness and training, site study set-up, protocol and...

CCS Associates, Inc. was awarded an indefinite delivery contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide comprehensive research support services. The contract has a potential value of $545,452,906 and a period of performance from September 2021 through August 2028. Two delivery orders have been issued against this contract to date. The first was a cost-plus-fixed-fee order for $208,825 to conduct vendor audits in San Jose,...

The National Institutes of Health National Human Genome Research Institute awarded an indefinite delivery contract to The Emmes Company LLC to provide clinical research support and collaboration services. Over the period of performance from July 2020 through June 2023, task orders valued at approximately $2.2M have been issued for protocol monitoring, data management, statistical expertise, regulatory assistance, and data and safety monitoring board support. Services are performed in Potomac,...

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to Lovelace Biomedical Research Institute on September 1, 2021 with a potential value of $545,452,906. Under the terms of the contract, Lovelace Biomedical Research Institute will provide a broad range of services to support biomedical research conducted by NIAID, including clinical trials, manufacturing and controls, nonclinical animal studies, analytics,...

The National Cancer Institute awarded an indefinite delivery/indefinite quantity multiple award contract to provide operational, administrative, regulatory, information technology, and logistical support services to support participation in multi-institutional cancer trials. Valued at up to $548 million over 10 years, the contract includes six task areas: project kick-off and transition activities, CTSU core support services and systems, awareness and training, site study set-up, protocol and...

The National Institutes of Health Office of Logistics and Acquisition Operations awarded an indefinite delivery contract to Sage Bionetworks of Seattle, Washington to provide SUPPORT AOURP AND (RCO) services. The single award IDV has a potential value of $1,220,558 and a period of performance from June 14, 2022 through July 10, 2023. No set asides were used. A subsequent delivery order against the IDV was awarded on August 2, 2022 with a value of $2,450,090 and period of performance through July...

The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to PPD Development LP with a potential value of $545,452,906 to provide comprehensive and rapid response capabilities for research programs through September 2028. Task orders issued against the contract include over $132 million for clinical trial management support services relating to COVID-19, as well as orders valued at $2.33 million, $2 million, and $82.5...

The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a single award indefinite delivery contract to Technical Resources International, Inc., doing business as Technical Resources Intl., with a potential value of $545,452,906 over a seven year ordering period. The contract aims to procure a broad range of services to support biomedical research conducted by NIAID, including clinical trials, manufacturing and controls, nonclinical animal studies,...